Inappropriate EPS Nomination and Service Direction

 This podcast outlines efforts by Community Pharmacy England to address and eliminate inappropriate Electronic Prescription Service (EPS) nominations and the unauthorized direction of patient services. By collaborating with NHS England and the British Medical Association, the organization is implementing stricter regulatory guidelines to ensure that medical providers do not manipulate where patients receive their medications. Key updates include a 2026/27 GP Contract amendment that requires doctors to reconfirm a patient’s chosen pharmacy when issuing new prescriptions. These measures aim to protect patient choice and prevent IT systems from automatically selecting dispensers without explicit consent. Ultimately, the initiative seeks to maintain professional integrity and transparency across the community pharmacy sector.